Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. [electronic resource]
Producer: 20180503Description: 1046-1052 p. digitalISSN:- 1442-200X
- Adolescent
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Child, Preschool
- Cytarabine -- therapeutic use
- Drug Administration Schedule
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Idarubicin -- therapeutic use
- Lenograstim
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Recombinant Proteins -- therapeutic use
- Recurrence
- Treatment Outcome
- Vidarabine -- analogs & derivatives
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.